This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Clinical Data Disclosure, Transparency and Plain Language Summaries
19 - 20 March, 2024
Hilton Philadelphia at Penn's Landing, PhiladelphiaHybrid Event I Attend Live In-Person or Online

Karen Heraty
Executive Director, Clinical Trial Registry and Transparency, Global Scientific Communications at Eli Lilly and Company


Karen is the capability leader for Clinical Transparency at Eli Lilly and Company. Her scope includes Plain Language Summaries, Clinical Trial Registrations and Results Posting, and Redaction/Submission Transparency, including EU Policy 70 and Health Canada submissions. Karen has worked in scientific communications at Lilly for over 25 years. She has led several process improvement and business initiatives that resulted in efficiencies within Lilly, including establishing and leading the scientific communications team at Lilly Capabilities Center India. Her recent accomplishments in transparency include establishing Lilly’s EU CTR process, EMA Policy 70 restart process, and refreshing and revamping Lilly’s Plain Language Summary program.

Agenda Sessions

  • KEYNOTE PANEL: CTIS Experience, Obstacles, Challenges and Meeting RFI Timelines